S&P 500 Falls 0.21% to 5051.41 — Data Talk
The S&P 500 Index is down 10.41 points or 0.21% today to 5051.41
--Down for three consecutive trading days
--Down 147.65 points or 2.84% over the last three trading days
--Largest three-day point decline since Friday, Oct. 20, 2023
--Largest three-day percentage decline since Friday, Oct. 27, 2023
--Down four of the past five trading days
--Off 3.86% from its record close of 5254.35 hit Thursday, March 28, 2024
--Up 49.93% from the Election Day close of 3369.16 on Tuesday, Nov. 3, 2020
--Up 31.14% from the Inauguration Day close of 3851.85 on Wednesday, Jan. 20, 2021
--Lowest closing value since Wednesday, Feb. 21, 2024
--Off 3.86% from its 52-week high of 5254.35 hit Thursday, March 28, 2024
--Up 24.54% from its 52-week low of 4055.99 hit Wednesday, April 26, 2023
--Rose 21.58% from 52 weeks ago
--Off 3.86% from its 2024 closing high of 5254.35 hit Thursday, March 28, 2024
--Up 7.74% from its 2024 closing low of 4688.68 hit Thursday, Jan. 4, 2024
--Month-to-date it is down 3.86%
--Year-to-date it is up 281.58 points or 5.90%
Data based on preliminary market closing values
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 16, 2024 16:31 ET (20:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track